Brazil's environment minister Izabella Teixeira has vowed to crack down harder on loggers clearing trees in the Amazon rainforest, after a sudden rise in deforestation. On 18 May, Brazil's National Institute for Space Research (INPE) released satellite data recording that 593 square kilometres of forest had been cleared in March and April, a 473% increase over the 103.5 square kilometres cut down in the same period last year. Much of the clearing occurred in the state of Mato Grosso (pictured, in 2008) , where soya-bean farming is common. At a crisis meeting, Teixeira said it was too early to tell whether the surge related to anticipated changes in legislation governing forest preservation, as environmentalists claim.
Deforestation surges in the Amazon

HIV scandal
The last plaintiff suing Japan's government and five biomedical companies over HIV infection caused
Three Gorges Dam
In an unusually frank assessment of problems caused by the controversial Three Gorges Dam in central China, the State Council, China's cabinet, has pledged to curb environmental deterioration in the area, and to tackle the pollution of water supplies downstream in the Yangtze River. Other problems that the council plans to address include the dam's potential to cause seismic disasters, and its effects on biological diversity. The 18 May statement came during a severe drought in provinces along the middle and lower reaches of the Yangtze that has devastated farmland and left millions of people short of drinking water. See go.nature.com/auffmx for more.
POLICY
Smallpox stocks
The World Health Organization (WHO) has failed to decide when to destroy the world's last two remaining stocks of the virus that causes smallpox. A meeting of the WHO's decision-making body, the World Health Assembly, this week was supposed to produce a deadline, but the organization ended up deferring judgement until the 67th assembly meeting, in 2014. A US resolution calling for the stocks to be maintained for at least another five years ran into opposition led by Iran. See go.nature.com/7gmgck for more.
BUSINESS
Hepatitis approvals
As expected, the US Food and Drug Administration has approved what is only the second drug to directly target the hepatitis C virus. Telaprevir (Incivek), marketed by Vertex Pharmaceuticals in Cambridge, Massachusetts, was given the green light on 23 May -10 days after the agency approved boceprevir (Victrelis) made by Merck of Whitehouse Station, New Jersey.
Carbon targets
On 17 May, Britain extended existing pledges to limit greenhouse-gas emissions beyond 2020. It plans to cut emissions to 50% below 1990 levels between 2023 and 2027. by tainted blood products settled last week for ¥28 million (US$340,000) in damages. Since 1989, nearly 1,400 patients -mostly haemophiliacs -have sued after being infected in the 1980s by blood coagulants that were not treated to kill viruses. In 1996, Naoto Kan, then health minister and now prime minister of Japan, admitted partial government responsibility in the scandal (see Nature 379, 663; 1996) . The court cases may now be closed, but the patients are stuck with the virus. The health ministry says that it will continue to support their treatment.
TEPCO's losses
The operators of Japan's stricken Fukushima nuclear power plant announced a net 
TREND WATCH
The price of uranium oxidethe raw material for uranium fuel -climbed steadily last year after an earlier price collapse. But since the disaster at the Fukushima Daiichi nuclear plant in Japan, the spot price has dropped by about 16%, reflecting uncertainty about prospects for nuclear energy. Ux Consulting, headquartered in Roswell, Georgia, has taken 10% off its projection of cumulative demand for uranium oxide to 2030, which now stands at around 2.3 billion kilograms. 
